NCBI Taxonomy: 1873

Daidzein

C15H10O4 (254.0579)

Daidzein is a member of the class of 7-hydroxyisoflavones that is 7-hydroxyisoflavone substituted by an additional hydroxy group at position 4. It has a role as an antineoplastic agent, a phytoestrogen, a plant metabolite, an EC 3.2.1.20 (alpha-glucosidase) inhibitor and an EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor. It is a conjugate acid of a daidzein(1-). Daidzein is a natural product found in Pericopsis elata, Thermopsis lanceolata, and other organisms with data available. Daidzein is an isoflavone extract from soy, which is an inactive analog of the tyrosine kinase inhibitor genistein. It has antioxidant and phytoestrogenic properties. (NCI) Daidzein is one of several known isoflavones. Isoflavones compounds are found in a number of plants, but soybeans and soy products like tofu and textured vegetable protein are the primary food source. Up until recently, daidzein was considered to be one of the most important and most studied isoflavones, however more recently attention has shifted to isoflavone metabolites. Equol represents the main active product of daidzein metabolism, produced via specific microflora in the gut. The clinical effectiveness of soy isoflavones may be a function of the ability to biotransform soy isoflavones to the more potent estrogenic metabolite, equol, which may enhance the actions of soy isoflavones, owing to its greater affinity for estrogen receptors, unique antiandrogenic properties, and superior antioxidant activity. However, not all individuals consuming daidzein produce equol. Only approximately one-third to one-half of the population is able to metabolize daidzein to equol. This high variability in equol production is presumably attributable to interindividual differences in the composition of the intestinal microflora, which may play an important role in the mechanisms of action of isoflavones. But, the specific bacterial species in the colon involved in the production of equol are yet to be discovered. (A3191, A3189). See also: Trifolium pratense flower (part of). Daidzein is one of several known isoflavones. Isoflavones compounds are found in a number of plants, but soybeans and soy products like tofu and textured vegetable protein are the primary food source. Up until recently, daidzein was considered to be one of the most important and most studied isoflavones, however more recently attention has shifted to isoflavone metabolites. Equol represents the main active product of daidzein metabolism, produced via specific microflora in the gut. The clinical effectiveness of soy isoflavones may be a function of the ability to biotransform soy isoflavones to the more potent estrogenic metabolite, equol, which may enhance the actions of soy isoflavones, owing to its greater affinity for estrogen receptors, unique antiandrogenic properties, and superior antioxidant activity. However, not all individuals consuming daidzein produce equol. Only approximately one-third to one-half of the population is able to metabolize daidzein to equol. This high variability in equol production is presumably attributable to interindividual differences in the composition of the intestinal microflora, which may play an important role in the mechanisms of action of isoflavones. But, the specific bacterial species in the colon involved in the production of equol are yet to be discovered. (PMID:18045128, 17579894). Daidzein is a biomarker for the consumption of soy beans and other soy products. Widespread isoflavone in the Leguminosae, especies Phaseolus subspecies (broad beans, lima beans); also found in soy and soy products (tofu, miso), chick peas (Cicer arietinum) and peanuts (Arachis hypogaea). Nutriceutical with anticancer and bone protective props. A member of the class of 7-hydroxyisoflavones that is 7-hydroxyisoflavone substituted by an additional hydroxy group at position 4. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor CONFIDENCE standard compound; INTERNAL_ID 937; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4894; ORIGINAL_PRECURSOR_SCAN_NO 4890 CONFIDENCE standard compound; INTERNAL_ID 937; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3575; ORIGINAL_PRECURSOR_SCAN_NO 3572 CONFIDENCE standard compound; INTERNAL_ID 937; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4858; ORIGINAL_PRECURSOR_SCAN_NO 4855 CONFIDENCE standard compound; INTERNAL_ID 937; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7978; ORIGINAL_PRECURSOR_SCAN_NO 7973 CONFIDENCE standard compound; INTERNAL_ID 937; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4898; ORIGINAL_PRECURSOR_SCAN_NO 4894 CONFIDENCE standard compound; INTERNAL_ID 937; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4884; ORIGINAL_PRECURSOR_SCAN_NO 4881 CONFIDENCE standard compound; INTERNAL_ID 937; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7989; ORIGINAL_PRECURSOR_SCAN_NO 7985 CONFIDENCE standard compound; INTERNAL_ID 937; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7952; ORIGINAL_PRECURSOR_SCAN_NO 7950 CONFIDENCE standard compound; INTERNAL_ID 937; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4852; ORIGINAL_PRECURSOR_SCAN_NO 4847 CONFIDENCE standard compound; INTERNAL_ID 937; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7907; ORIGINAL_PRECURSOR_SCAN_NO 7904 CONFIDENCE standard compound; INTERNAL_ID 937; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7956; ORIGINAL_PRECURSOR_SCAN_NO 7952 CONFIDENCE standard compound; INTERNAL_ID 937; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7917; ORIGINAL_PRECURSOR_SCAN_NO 7913 CONFIDENCE Reference Standard (Level 1); NaToxAq - Natural Toxins and Drinking Water Quality - From Source to Tap (https://natoxaq.ku.dk) Acquisition and generation of the data is financially supported in part by CREST/JST. CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2315 IPB_RECORD: 1801; CONFIDENCE confident structure IPB_RECORD: 421; CONFIDENCE confident structure CONFIDENCE standard compound; INTERNAL_ID 8828 CONFIDENCE standard compound; INTERNAL_ID 2874 CONFIDENCE standard compound; INTERNAL_ID 4239 CONFIDENCE standard compound; INTERNAL_ID 4163 CONFIDENCE standard compound; INTERNAL_ID 181 Daidzein is a soy isoflavone, which acts as a PPAR activator. Daidzein is a soy isoflavone, which acts as a PPAR activator. Daidzein is a soy isoflavone, which acts as a PPAR activator.

Sisomicin

C19H37N5O7 (447.2693)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic KEIO_ID S047; [MS3] KO009246 KEIO_ID S047; [MS2] KO009245 KEIO_ID S047

staurosporine

C28H26N4O3 (466.2005)

C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D004791 - Enzyme Inhibitors Staurosporine is a potent, ATP-competitive and non-selective inhibitor of protein kinases with IC50s of 6 nM, 15 nM, 2 nM, and 3 nM for PKC, PKA, c-Fgr, and Phosphorylase kinase respectively. Staurosporine also inhibits TAOK2 with an IC50 of 3 μM. Staurosporine is an apoptosis inducer[1][2][3][4][5].

Gentamicin

C21H43N5O7 (477.3162)

A complex of three different closely related aminoglycoside sulfates, Gentamicins C1, C2, and C1(subA), obtained from Micromonospora purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit protein synthesis (genetic translation). [PubChem] D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic

Mikamycin A

C28H35N3O7 (525.2475)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D025361 - Streptogramins Virginiamycin M1 (Pristinamycin IIA; Ostreogrycin A), produced by?Streptomyces virginiae, is an polyunsaturated macrocyclic lactone antibiotic and acts as a component of Virginiamycin (HY-112665)[1]. Virginiamycin M1 alone is against Staphylococcus aureus with a MIC of 0.25 μg/mL. The combination of Virginiamycin M1 and Virginiamycin S1 (HY-N6680) is 0.125 μg/mL (MIC Value), which can improve the bactericidal effect 1-30 times[2].

Dynemicin A

C30H19NO9 (537.106)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000970 - Antineoplastic Agents

Megalomicin A

C44H80N2O15 (876.5558)

C254 - Anti-Infective Agent > C276 - Antiparasitic Agent

Megalomicin B

C46H82N2O16 (918.5664)

Megalomicin C1

C48H84N2O17 (960.577)

Megalomicin C2

C49H86N2O17 (974.5926)

Mirosamicin

C37H61NO13 (727.4143)

C784 - Protein Synthesis Inhibitor > C261 - Macrolide Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

Mycinamicin VII

C29H47NO7 (521.3352)

Mycinamicin VIII

C29H47NO6 (505.3403)

Protomycinolide IV

C21H32O4 (348.23)

Thiocoraline

C48H56N10O12S6 (1156.2403)

Gentamicin A2

C17H33N3O11 (455.2115)

Gentamicin X2

C19H38N4O10 (482.2588)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins

Sagamicin

C20H41N5O7 (463.3006)

Micronomicin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=52093-21-7 (retrieved 2024-10-09) (CAS RN: 52093-21-7). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Astromicin

C17H35N5O6 (405.2587)

An amino cyclitol glycoside that is L-chiro-inositol in which the hydroxy groups at positions 1, 4, and 6 are replaced by aminoacetyl)methylamino, amino, and methoxy groups, respectively, and in which the hydroxy group at position 3 is converted to the corresponding 2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranoside. The major component of fortimicin, obtained from Micromonospora olivasterospora. It is administered (as the sulfate salt) by intramuscular injection or intravenous infusion for the treatment of severe systemic infections due to sensitive Gram-negative organisms. C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

Aclarubicin

C42H53NO15 (811.3415)

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors

Mycinamicin I

C37H61NO12 (711.4194)

Mycinamicin IV

C37H61NO11 (695.4244)

A mycinamicin composed of a 16-membered ring macrolactone core, an N,N-dimethylated deoxysugar desosamine and a 2,3-di-O-methylated 6-deoxysugar mycinose.

Mycinamicin V

C37H61NO12 (711.4194)

Indolmycin

C14H15N3O2 (257.1164)

A member of the class of 1,3-oxazoles that is 1,3-oxazol-4(5H)-one which is substituted at the 2 and 5-pro-S positions by methylamino and [(1R)-1-(1H-indol-3-yl)ethyl] groups, respectively.

miconazole

C18H14Cl4N2O (413.986)

G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AF - Imidazole derivatives A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AC - Imidazole derivatives A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AC - Imidazole and triazole derivatives J - Antiinfectives for systemic use > J02 - Antimycotics for systemic use > J02A - Antimycotics for systemic use > J02AB - Imidazole derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065688 - Cytochrome P-450 CYP2C9 Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065692 - Cytochrome P-450 CYP3A Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058888 - 14-alpha Demethylase Inhibitors S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent CONFIDENCE standard compound; INTERNAL_ID 2706 CONFIDENCE standard compound; INTERNAL_ID 8602

Mycinamicin III

C36H59NO11 (681.4088)

A mycinamicin composed of a 16-membered ring macrolactone core, an N,N-dimethylated deoxysugar desosamine and a 2-O-methylated 6-deoxysugar javose.

Mycinamicin VI

C35H57NO11 (667.3931)

A mycinamicin composed of a 16-membered ring macrolactone core, an N,N-dimethylated deoxysugar desosamine and a 6-deoxysugar 6-deoxyallose.

Miconazole

C18H14Cl4N2O (413.986)

Miconazole is only found in individuals that have used or taken this drug. It is an imidazole antifungal agent that is used topically and by intravenous infusion. [PubChem]Miconazole interacts with 14-α demethylase, a cytochrome P-450 enzyme necessary to convert lanosterol to ergosterol. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular contents. Miconazole may also inhibit endogenous respiration, interact with membrane phospholipids, inhibit the transformation of yeasts to mycelial forms, inhibit purine uptake, and impair triglyceride and/or phospholipid biosynthesis. G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AF - Imidazole derivatives A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AC - Imidazole derivatives A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AC - Imidazole and triazole derivatives J - Antiinfectives for systemic use > J02 - Antimycotics for systemic use > J02A - Antimycotics for systemic use > J02AB - Imidazole derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065688 - Cytochrome P-450 CYP2C9 Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065692 - Cytochrome P-450 CYP3A Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058888 - 14-alpha Demethylase Inhibitors S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent

geneticin

C20H40N4O10 (496.2744)

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins

Astromicin

C17H35N5O6 (405.2587)

Diazepinomicin

C28H34N2O4 (462.2518)

Micronomicin

C20H41N5O7 (463.3006)

Rosamicin

C31H51NO9 (581.3564)

Crisamicin C

C32H22O13 (614.106)

1-Hydroxycrisamicin A

C32H22O13 (614.106)

An organic heterotetracyclic compound isolated from the culture broth of Micromonospora sp. SA-246. It exhibits potent antibacterial activity against several Gram-positive bacterial strains.

Daidzein

C15H10O4 (254.0579)

Annotation level-1 Disclaimer: While authors make an effort to ensure that the content of this record is accurate, the authors make no representations or warranties in relation to the accuracy or completeness of the record. This record do not reflect any viewpoints of the affiliation and organization to which the authors belong. Daidzein is a soy isoflavone, which acts as a PPAR activator. Daidzein is a soy isoflavone, which acts as a PPAR activator. Daidzein is a soy isoflavone, which acts as a PPAR activator.

GTRI-02

C13H14O4 (234.0892)

A member of the class tetralins that is 3,4-dihydronaphthalen-1(2H)-one substituted by an acetyl, two hydroxy and methyl groups at positions 7, 3, 6 and 8 respectively. It isolated from Micromonospora and acts as an inhibitor of lipid peroxidation.

12-(3-acetyloxiran-2-yl)dodecanoic Acid

C16H28O4 (284.1987)

9-hydroxy-8-methylundeca-4,6-dien-3-one

C12H20O2 (196.1463)

5-hydroxy-4-methylhept-2-enoic acid

C8H14O3 (158.0943)

7-hydroxy-6-methylnona-2,4-dienoic acid

C10H16O3 (184.1099)

2-ethyl-1-hydroxy-8-methoxy-3-methyl-9,10-anthraquinone|2-ethyl-1-hydroxy-8-methoxy-3-methylanthraquinone

C18H16O4 (296.1049)

SCHEMBL16226021

C20H18O6 (354.1103)

Geneticin

C20H40N4O10 (496.2744)

An aminoglycoside antibiotic produced by Micromonospora rhodorangea. It blocks polypeptide synthesis by inhibiting the elongation step in both prokaryotic and eukaryotic cells.

gentamicin

C21H43N5O7 (477.3162)

D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic

3Z-Tetradecenenitrile

C14H25N (207.1987)

3-Methyl-1H-indole-2-carboxylic acid

C10H9NO2 (175.0633)

Lipiarmycin

C52H74Cl2O18 (1056.4252)

A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C784 - Protein Synthesis Inhibitor > C261 - Macrolide Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic Fidaxomicin (OPT-80), a macrocyclic antibiotic, is an orally active and potent RNA polymerase inhibitor. Fidaxomicin has a narrow spectrum of antibacterial activity and a good anti-Clostridium difficile activity (MIC90=0.12?μg/mL). Fidaxomicin can be used for Clostridium difficile infection (CDI) research[1][2][3].

Diazepinomicin

C28H34N2O4 (462.2518)

C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor

6-Deoxydaunomycin

C27H29NO9 (511.1842)

Gentamycin C1

C21H43N5O7 (477.3162)

D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors

Virginiamycin M1

C28H35N3O7 (525.2475)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D025361 - Streptogramins C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic Virginiamycin M1 (Pristinamycin IIA; Ostreogrycin A), produced by?Streptomyces virginiae, is an polyunsaturated macrocyclic lactone antibiotic and acts as a component of Virginiamycin (HY-112665)[1]. Virginiamycin M1 alone is against Staphylococcus aureus with a MIC of 0.25 μg/mL. The combination of Virginiamycin M1 and Virginiamycin S1 (HY-N6680) is 0.125 μg/mL (MIC Value), which can improve the bactericidal effect 1-30 times[2].

K 251b

C15H10O4 (254.0579)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor Daidzein is a soy isoflavone, which acts as a PPAR activator. Daidzein is a soy isoflavone, which acts as a PPAR activator. Daidzein is a soy isoflavone, which acts as a PPAR activator.

7-Acetyl-3,6-dihydroxy-8-methyl-tetralone

C13H14O4 (234.0892)

lupinacidin C

C21H22O5 (354.1467)

A natural product found in Micromonospora lupini str. Lupac 08.

Mycinamicin II

C37H61NO13 (727.4143)

Maklamicin

C32H44O6 (524.3138)

1-(a-Ribofuranosyl)-lumichrome

C17H18N4O6 (374.1226)

Micronomicin

C20H41N5O7 (463.3006)

Micronomicin is an antibiotic that belongs to the aminoglycoside class of organic compounds. Aminoglycosides are characterized by aminocyclitols linked to amino sugars, forming aminoglycoside antibiotics. These compounds are known for their broad-spectrum activity against various microorganisms, particularly bacteria. Micronomicin, specifically, features a structure where an aminocyclitol is connected to an amino sugar through a glycosidic bond. This structure is typical of aminoglycosides and contributes to their antimicrobial properties. The exact configuration and arrangement of atoms in micronomicin give it its specific antimicrobial profile. Micronomicin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=52093-21-7 (retrieved 2024-10-09) (CAS RN: 52093-21-7). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

(1R,2R,3R,6E,8S,9S,10S,12R,14E,16R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-8,10,12-trimethyl-4,17-dioxabicyclo[14.1.0]heptadeca-6,14-diene-5,13-dione

C37H61NO12 (711.4194)

3-methyl-2-indolic acid

C10H9NO2 (175.0633)

An indolecarboxylic acid that is indole-2-carboxylic acid in which the hydrogen at position 3 is replaced by a methyl group.

(2r,3as,3'ar,6s,7r,7'r,7as,7'as)-6-{[(2s,3s,4s,5s,6r)-4,5-dihydroxy-3-methoxy-6-(methoxymethyl)oxan-2-yl]oxy}-7-hydroxy-octahydro-2'h,3ah-2,4'-spirobi[[1,3]dioxolo[4,5-c]pyran]-7'-yl 2,4-dihydroxy-6-methylbenzoate

C27H36O17 (632.1952)

5-amino-4-(2-hydroxy-3,4-dimethoxyphenyl)-6-(6-methoxy-5,8-dioxo-7-{[(2r)-3-oxobutan-2-yl]amino}quinolin-2-yl)-3-methylpyridine-2-carboxylic acid

C29H28N4O9 (576.1856)

2-[(3s,14s,15s)-15-(heptadecan-2-yl)-5,13-dihydroxy-7,14-dimethyl-11-methylidene-2,8-dioxo-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

C33H56N4O7 (620.4149)

n-[(2r,3r,4s,6r)-6-{[(5s,6r,9s,11z,13s,16s,18s,20s,21r,22s)-17-{[(2r,4r,5r,6s)-5-(acetyloxy)-4-hydroxy-6-methyloxan-2-yl]oxy}-3-formyl-5,23-dihydroxy-8,12,18,20,22-pentamethyl-25,27-dioxo-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-3,7,11,14,23-pentaen-9-yl]oxy}-2,4-dimethyl-4-nitrooxan-3-yl]methoxycarboximidic acid

C49H66N2O17 (954.4361)

21-hydroxy-4-(hydroxymethyl)-3-(2-hydroxypropyl)-6,10,16,20-tetramethyl-24-oxapentacyclo[20.2.1.0¹,⁶.0¹¹,²⁰.0¹⁴,¹⁹]pentacosa-4,8,12,21-tetraene-23,25-dione

C32H44O6 (524.3138)

(4e,18e,20e)-7,9,11,12,13,14,15-heptahydroxy-10-{[(2s,5r,6r)-5-hydroxy-6-methyloxan-2-yl]oxy}-6'-(3-hydroxypentan-2-yl)-22-(2-hydroxypropyl)-5',6,8,16,28,29-hexamethyl-14-propyl-2,26-dioxaspiro[bicyclo[23.3.1]nonacosane-27,2'-oxane]-4,18,20-trien-3-one

C54H94O16 (998.6542)

(1s,9s,12s,15r,16e,20e,23r,24r,27s)-12-[(2s)-1-[(1s,3s,4s)-3,4-dihydroxycyclohexyl]propan-2-yl]-1-hydroxy-15-(hydroxymethyl)-23,27-dimethyl-11,28-dioxa-4-azatricyclo[22.3.1.0⁴,⁹]octacosa-16,20-diene-2,3,10,22-tetrone

C37H57NO10 (675.3982)

(11s,15s,17r)-7,17-dihydroxy-5-[(11s,15s,17s)-7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraen-5-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione

C32H22O13 (614.106)

10-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-8,11-dihydroxy-8-(1-hydroxyethyl)-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione

C27H31NO9 (513.1999)

(1r,9s,12s,15s,16e,20e,23r,24s,27r)-12-[(2r)-1-[(1s,2s,3s,4r)-2,4-dihydroxy-3-methoxycyclohexyl]propan-2-yl]-1-hydroxy-15,23,27-trimethyl-11,28-dioxa-4-azatricyclo[22.3.1.0⁴,⁹]octacosa-16,20-diene-2,3,10,22-tetrone

C38H59NO10 (689.4139)

n-[(2r,3r,4s,6r)-6-{[(1s,5s,6r,9s,11e,13s,16s,17s,18s,20s,21r,22s)-17-{[(2r,4r,5s,6s)-5-(acetyloxy)-4-{[(2s,4r,5r,6s)-5-{[(2r,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5,23-dihydroxy-8,12,18,20,22-pentamethyl-25,27-dioxo-3-[(1e)-3-oxobut-1-en-1-yl]-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-3,7,11,14,23-pentaen-9-yl]oxy}-4-amino-2,4-dimethyloxan-3-yl]methoxycarboximidic acid

C64H92N2O21 (1224.6192)

8,10,12-trihydroxy-11,13,15,17,19-pentamethyl-20-(4-oxohexyl)-1-oxacycloicosa-3,5,15-trien-2-one

C30H50O6 (506.3607)

(2s)-3-{[(1r,2s,6z,8s,9s,10s,12r,16s)-9-{[(2s,3r,4s)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-2-hydroxy-2-({[(2r,3r,4r,5r,6r)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxy}methyl)-8,10,12-trimethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-6-en-15-yl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

C42H70N2O16S (890.4446)

(16s,17r,18r)-8,11,17,18-tetrahydroxy-16-methyl-13,14-diazapentacyclo[10.6.1.0²,¹⁰.0⁴,⁹.0¹⁵,¹⁹]nonadeca-1(19),2(10),4,6,8,11,14-heptaen-3-one

C18H14N2O5 (338.0903)

(3s,4r,5e,9s,10r,11e,13s,14s)-14-ethyl-4,10-dihydroxy-3,5,9,11,13-pentamethyl-1-oxacyclotetradeca-5,11-diene-2,7-dione

C20H32O5 (352.225)

(4s,6s,8s,9r,12r,16s)-8-hydroxy-4,6-dimethyl-17-oxa-2-azatetracyclo[7.6.2.0⁴,¹⁶.0¹²,¹⁶]heptadec-1(15)-ene-3,5,14-trione

C17H21NO5 (319.142)

(1s,3s,6s,7e,10e,13r,16r,17s,18s,21r,22s,23e)-17-{[(2r,4r,5s,6r)-5-(3,5-dichloro-1h-pyrrole-2-amido)-4-hydroxy-6-methyloxan-2-yl]oxy}-3,22-diethyl-23-hydroxy-6,18-dimethyl-25,27-dioxo-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-4,7,10,14,23-pentaene-4-carboxylic acid

C44H54Cl2N2O10 (840.3155)

(2s,3r,4s,5s)-2-{[(1s,2s,3s,4r,5r,6r)-2,4-diamino-5-{[(2s,3r,6r)-3-amino-6-[(methylamino)methyl]oxan-2-yl]oxy}-3,6-dihydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol

C20H41N5O8 (479.2955)

10-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-8,11-dihydroxy-8-(2-hydroxyacetyl)-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione

C27H29NO10 (527.1791)

6-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-16-ethyl-4-hydroxy-7-(2-hydroxyethyl)-5,9,13,15-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

C31H53NO8 (567.3771)

(2s,3s,4r,6r,8s,11s,13r,15r)-13,18-dihydroxy-6-methyl-2-(2-oxopropyl)-16-oxatetracyclo[13.2.2.0³,¹¹.0⁴,⁸]nonadeca-1(18),9-diene-7,17-dione

C22H28O6 (388.1886)

26-amino-2,15,17,23-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,27,29-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,21,23,25-octaen-13-yl acetate

C37H46N2O12 (710.3051)

(1r,2r,3r,6e,8s,9s,12s,14e,16r)-9-{[(2r,3r,4r,6s)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-2-hydroxy-2-({[(2s,3r,4s,5r,6r)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxy}methyl)-8,12-dimethyl-4,17-dioxabicyclo[14.1.0]heptadeca-6,14-diene-5,13-dione

C36H59NO13 (713.3986)

(10s,11s,12e,17e,19e,21r)-14,21-dihydroxy-10-isopropyl-11,19-dimethyl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.0³,⁷]octacosa-1(27),6,12,14,17,19,25(28)-heptaene-2,8,23-trione

C28H35N3O7 (525.2475)

17-methyl-5-{2,7,9-trihydroxy-17-methyl-13-oxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1,3,5,7,9-pentaen-5-yl}-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3(8),5-triene-2,4,7,9,13-pentone

C32H22O13 (614.106)

(2r,3r,4r,5r)-2-{[(1s,2s,3r,4s,6r)-4,6-diamino-3-{[(2s,3r)-3-amino-6-[(methylamino)methyl]-3,4-dihydro-2h-pyran-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol

C20H39N5O7 (461.2849)

(2r,3r,4r,6s)-6-[(2r,3ar,4r,4'r,5's,6s,6'r,7s,7ar)-6-{[(2s,3r,4r,5s,6r)-2-{[(2r,3s,4s,5s,6s)-6-[(2r,3as,3'ar,6s,7r,7'r,7as,7'as)-7'-(2,4-dihydroxy-6-methylbenzoyloxy)-octahydro-2'h,3ah-2,4'-spirobi[[1,3]dioxolo[4,5-c]pyran]-7-oloxy]-4-hydroxy-5-methoxy-2-(methoxymethyl)oxan-3-yl]oxy}-3-hydroxy-5-methoxy-6-methyloxan-4-yl]oxy}-4,6',7a-trimethyl-tetrahydrospiro[[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-4',7-dioloxy]-4-{[(2s,4s,5r,6s)-5-methoxy-4,6-dimethyl-4-nitrooxan-2-yl]oxy}-2-methyloxan-3-yl 3-chloro-4-hydroxy-2-methoxy-6-methylbenzoate

C70H98ClNO38 (1595.5455)

2-[(1r,2s,3r,7r,8s,9s,10s,12s,14e,16s)-9-{[(2r,3s,4r,6s)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde

C31H51NO9 (581.3564)

(6e,13e,15e)-16-{6-[(3e,5e)-6-(4,5-dihydroxy-5,6-dimethyloxan-3-yl)-3-methylhexa-3,5-dien-1-yl]-4,6-dimethoxyoxan-2-yl}-10-ethyl-5,9,11-trihydroxy-3-methoxy-2,6,12-trimethyl-n-{2-methyl-1-[(4-methyl-2-oxo-5-phenyloxolan-3-yl)-c-hydroxycarbonimidoyl]propyl}hexadeca-6,13,15-trienimidic acid

C59H92N2O14 (1052.6548)

2,3,20,23,27-pentahydroxy-6-methoxy-4-methyl-18,25-dioxo-15-azaheptacyclo[14.12.0.0²,⁷.0³,¹⁴.0⁸,¹³.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-1(16),5,8,10,12,17(26),19,21,23,27-decaene-5-carboxylic acid

C30H23NO10 (557.1322)

(2r,3r,4s,5s)-2-{[(1s,2s,3r,4s,6r)-4,6-diamino-3-{[(2s,3r)-3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-4-(methylamino)oxane-3,5-diol

C18H35N5O7 (433.2536)

10-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-8-ethyl-8,11-dihydroxy-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione

C27H31NO8 (497.205)

n-[(2r,3s,4r,6r)-6-{[(1s,5r,6s,7e,9s,11z,13s,16r,17r,18r,20r,21s,22r)-3-formyl-5,27-dihydroxy-17-{[(2r,4r,5s,6r)-4-{[(2r,5r,6r)-5-{[(2r,4s,5s,6s)-4-hydroxy-5-{[(2r,5s,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyl-5-[(2-methylpropanoyl)oxy]oxan-2-yl]oxy}-8,12,18,20,22-pentamethyl-23,25-dioxo-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-3,7,11,14,24(27)-pentaen-9-yl]oxy}-2,4-dimethyl-4-nitrooxan-3-yl]methoxycarboximidic acid

C69H100N2O24 (1340.6666)

6-({17-[({5-[2-(3,5-dichloro-2-ethyl-4,6-dihydroxyphenyl)-1-hydroxy-2-oxoethyl]-4-hydroxy-3-methoxy-6-methyloxan-2-yl}oxy)methyl]-9-ethyl-12-hydroxy-2-(1-hydroxyethyl)-5,7,11-trimethyl-18-oxo-1-oxacyclooctadeca-4,6,10,14,16-pentaen-8-yl}oxy)-3,5-dihydroxy-2,2-dimethyloxan-4-yl 2-methylpropanoate

C53H76Cl2O18 (1070.4408)

hexadec-3-enenitrile

C16H29N (235.23)

(7z,10s,11r,12r,13r,14r,15r,16s,17s,18e,20z)-2,4,10,12,14,16,22-heptahydroxy-9-(hydroxymethyl)-3,7,11,13,15,17-hexamethyl-23-azatricyclo[22.3.1.0⁵,²⁷]octacosa-1(27),2,4,7,18,20,22,24-octaene-6,26,28-trione

C34H43NO11 (641.2836)

2,6,7-trihydroxy-3-methyl-4,11-dioxo-1h,2h,3h-cyclohexa[a]fluoren-1-yl 2-methylpropanoate

C22H20O7 (396.1209)

(6e)-10,13,14-trihydroxy-4,14,16-trimethyl-17-(11-methyldodecyl)-8-methylidene-1-oxa-4,9,12-triazacycloheptadeca-6,9,12-triene-2,5,15-trione

C30H49N3O7 (563.357)

(1r,8s,11r,15s)-6-methyl-2-(2-oxopropyl)-16-oxapentacyclo[13.2.2.0¹,¹³.0³,¹¹.0⁴,⁸]nonadec-9-ene-7,17,18-trione

C22H26O5 (370.178)

n-[(2r,3r,4s,6r)-6-{[(1s,5s,6r,9s,11e,13s,16s,17s,18s,20s,21r,22s)-17-{[(2r,4r,5s,6s)-5-(acetyloxy)-4-{[(2s,4r,5r,6s)-5-{[(2r,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5,23-dihydroxy-8,12,18,20,22-pentamethyl-25,27-dioxo-3-[(1e)-3-oxobut-1-en-1-yl]-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-3,7,11,14,23-pentaen-9-yl]oxy}-2,4-dimethyl-4-nitrooxan-3-yl]methoxycarboximidic acid

C64H90N2O23 (1254.5934)

6-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-7,16-diethyl-4-hydroxy-5,9,13,15-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

C31H53NO7 (551.3822)

(1s,2e,8e,12e)-1,4,4,8,12-pentamethylcyclopentadeca-2,8,12-trien-1-ol

C20H34O (290.261)

(1r,8s,11s,14s,15e,19e,22r,23s,26r)-11-[(2r)-1-[(1s,3r,4r)-3,4-dihydroxycyclohexyl]propan-2-yl]-1-hydroxy-14,22,26-trimethyl-10,27-dioxa-4-azatricyclo[21.3.1.0⁴,⁸]heptacosa-15,19-diene-2,3,9,21-tetrone

C36H55NO9 (645.3877)

4-(dimethylamino)-5-methoxy-6-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),17,20(27),21(26),22,24-decaene-3,18-diol

C29H28N4O4 (496.211)

(2r,3r,4r,6s)-6-[(2r,3ar,4r,4'r,5's,6s,6'r,7s,7ar)-6-{[(2s,3r,4r,5s,6r)-2-{[(2r,3s,4s,5s,6s)-6-[(2r,3as,3'ar,6s,7r,7'r,7as,7'as)-7'-(2,4-dihydroxy-6-methylbenzoyloxy)-octahydro-2'h,3ah-2,4'-spirobi[[1,3]dioxolo[4,5-c]pyran]-7-oloxy]-4-hydroxy-5-methoxy-2-(methoxymethyl)oxan-3-yl]oxy}-3-hydroxy-5-methoxy-6-methyloxan-4-yl]oxy}-4,6',7a-trimethyl-tetrahydrospiro[[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-4',7-dioloxy]-4-{[(2s,4s,5r,6s)-5-hydroxy-4,6-dimethyl-4-nitrooxan-2-yl]oxy}-2-methyloxan-3-yl 3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoate

C69H95Cl2NO38 (1615.4909)

(3r,4s,6s)-10,13-dihydroxy-6-methyl-7,18-dioxo-5-oxapentacyclo[9.7.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(11),2(8),9,12,14,16-hexaen-3-yl 4-methylhexanoate

C25H24O7 (436.1522)

(3s)-3-[(2r,3r,4s,5r,6r)-4-(acetyloxy)-3-hydroxy-5-{[(2z)-2-isothiocyanatobut-2-enoyl]oxy}-6-methyloxan-2-yl]-2,3-dihydroxy-6-imino-5-oxocyclohex-1-ene-1-carboxylic acid

C20H22N2O11S (498.0944)

5-methoxy-3,6-bis(phenylmethylidene)pyrazin-2-ol

C19H16N2O2 (304.1212)

(3e,5s,6s,7r,9s,10r,11e,13z,15s,16r)-6-{[(2r,3r,4r,6s)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-16-ethyl-10-hydroxy-15-({[(2s,3r,4s,5r,6r)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxy}methyl)-5,7,9-trimethyl-1-oxacyclohexadeca-3,11,13-trien-2-one

C37H63NO11 (697.4401)

2,3,6,20,23,27-hexahydroxy-4-methyl-15-azaheptacyclo[14.12.0.0²,⁷.0³,¹⁴.0⁸,¹³.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-1(16),8,10,12,17(26),19,21,23,27-nonaene-5,18,25-trione

C28H21NO9 (515.1216)

(11z,13z)-6-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-16-ethyl-4-hydroxy-7-(2-hydroxyethyl)-5,9,13,15-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

C31H53NO8 (567.3771)

3-hydroxy-8-methoxy-1-propylanthracene-9,10-dione

C18H16O4 (296.1049)

n-[(1z)-2-[(1s,2r,3r,7r,8s,9s,10r,12r,14e,16s)-9-{[(2s,3s,4s,6s)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]ethylidene]ethanehydrazonic acid

C33H55N3O9 (637.3938)

methyl 24-{[5-({5-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-4,6-dimethyl-4-nitrooxan-2-yl}oxy)-4-hydroxy-6-methyloxan-2-yl]oxy}-23-(dimethylamino)-4,8,12,22-tetrahydroxy-1,12-dimethyl-6,17-dioxo-20,25-dioxahexacyclo[19.3.1.0²,¹⁹.0⁵,¹⁸.0⁷,¹⁶.0⁹,¹⁴]pentacosa-2,4,7(16),8,14,18-hexaene-13-carboxylate

C48H62N2O21 (1002.3845)

(11z,13z)-6-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-7,16-diethyl-4-hydroxy-5,9,13,15-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

C31H53NO7 (551.3822)

(8s,9r,11r,13r)-3,8,14-trihydroxy-11,13-dimethyl-17-oxa-15-azatricyclo[7.6.2.0⁵,¹⁶]heptadeca-1,3,5(16),14-tetraen-12-one

C17H21NO5 (319.142)

n-{6-[(17-{[5-(acetyloxy)-4-{[5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5,23-dihydroxy-8,12,18,20,22-pentamethyl-25,27-dioxo-3-(3-oxobut-1-en-1-yl)-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-3,7,11,14,23-pentaen-9-yl)oxy]-2,4-dimethyl-4-nitrooxan-3-yl}methoxycarboximidic acid

C70H100N2O24 (1352.6666)

(2s,3s,4s,5s,6r)-5-methoxy-6-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),17,20(27),21(26),22,24-decaene-3,18-diol

C28H26N4O4 (482.1954)

9-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-2-hydroxy-2-{[(5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl)oxy]methyl}-3,8,10,12-tetramethyl-4,17-dioxabicyclo[14.1.0]heptadeca-6,14-diene-5,13-dione

C36H59NO13 (713.3986)

2-[5,13-dihydroxy-7,14-dimethyl-15-(15-methylhexadecan-2-yl)-11-methylidene-2,8-dioxo-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

C33H56N4O7 (620.4149)

2-[(7r,8s,9s,10r,12r,14e,16s)-9-{[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde

C31H51NO9 (581.3564)

(2s,3s,4r,6r,8s,11s)-6-methyl-2-(2-oxopropyl)-16-oxapentacyclo[13.2.2.0¹,¹³.0³,¹¹.0⁴,⁸]nonadec-9-ene-7,17,18-trione

C22H26O5 (370.178)

(1z,3r,4r,6r,8r,11r,13r,15r)-13-hydroxy-6-methyl-16-oxatetracyclo[13.2.2.0³,¹¹.0⁴,⁸]nonadeca-1,9-diene-7,17,18-trione

C19H22O5 (330.1467)

26-(1,2-dihydroxyethyl)-4,24-dihydroxy-25-oxa-16-azahexacyclo[15.7.2.0¹,²⁶.0²,¹⁵.0⁵,¹⁴.0⁷,¹²]hexacosa-2,4,7,9,11,14,20-heptaen-18,22-diyne-6,13-dione

C26H17NO7 (455.1005)

4-[2-(10,15-dihydroxy-8-methoxy-3-methyl-1,5,9,14,16-pentaoxo-2-azahexaphen-2-yl)acetyl]-6-hydroxy-5-methyl-3,5-dihydro-2h-pyrazine-2-carboxylic acid

C35H25N3O12 (679.1438)

(16s,17s,18r)-8,11,16,17,18-pentahydroxy-16-methyl-13,14-diazapentacyclo[10.6.1.0²,¹⁰.0⁴,⁹.0¹⁵,¹⁹]nonadeca-1(19),2(10),4,6,8,11,14-heptaen-3-one

C18H14N2O6 (354.0852)

(1r,9s,12s,15s,16e,20e,23r,24s,27r)-12-[(2r)-1-[(1s,3r,4r)-3,4-dihydroxycyclohexyl]propan-2-yl]-1-hydroxy-15,23,27-trimethyl-11,28-dioxa-4-azatricyclo[22.3.1.0⁴,⁹]octacosa-16,20-diene-2,3,10,22-tetrone

C37H57NO9 (659.4033)

(8e)-6-ethyl-1,7-dihydroxy-13-methoxy-3,7,9,11-tetramethyl-5,14-dioxabicyclo[11.2.1]hexadec-8-ene-2,4-dione

C21H34O7 (398.2304)

2-amino-3-{[2-(9-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl)-1-hydroxyethyl]sulfanyl}propanoic acid

C34H58N2O11S (702.3761)

8-hydroxy-4,6-dimethyl-17-oxa-2-azatetracyclo[7.6.2.0⁴,¹⁶.0¹²,¹⁶]heptadec-1(15)-ene-3,5,14-trione

C17H21NO5 (319.142)

(2r,3s,4r,5r)-2-{[(1s,2r,3r,4s,6r)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol

C13H27N3O6 (321.19)

(z)-(hydroxyimino)(1-hydroxypropan-2-yl)oxidoazanium

C3H8N2O3 (120.0535)

(6e)-8-[(2r,3s,4s,5r,6s)-6-[(1e,3e,9e,11e,13e)-14-[(3s,4s,5s,6r)-4,5-dihydroxy-5,6-dimethyloxan-3-yl]-6-methoxy-11-methyl-8-oxotetradeca-1,3,9,11,13-pentaen-1-yl]-3-ethyl-4-hydroxy-5-methyloxan-2-yl]-5-hydroxy-3-methoxy-2,6-dimethyl-n-(2-methyl-1-{[(3s,4s,5s)-4-methyl-2-oxo-5-phenyloxolan-3-yl]-c-hydroxycarbonimidoyl}propyl)oct-6-enimidic acid

C58H86N2O13 (1018.613)

(2r,3r,4s,5s)-2-{[(1r,2r,3r,4s,6r)-4,6-diamino-3-{[(2s,3s,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol

C19H38N4O10 (482.2588)

(2r,3s,4s,7r,14s)-2-chloro-3,20,23,27-tetrahydroxy-6-methoxy-4-methyl-18,25-dioxo-15-azaheptacyclo[14.12.0.0²,⁷.0³,¹⁴.0⁸,¹³.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-1(16),5,8,10,12,17(26),19,21,23,27-decaene-5-carboxylic acid

C30H22ClNO9 (575.0983)

(14z)-9-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-10-(2-hydroxyethyl)-2,8,12,16-tetramethyl-4,17-dioxabicyclo[14.1.0]heptadec-14-ene-5,13-dione

C31H53NO9 (583.372)

(11e,13e)-6-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-16-ethyl-4-hydroxy-7-(2-hydroxyethyl)-5,9,13,15-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

C31H53NO8 (567.3771)

(6e,14r,16s,17s)-10,13,14-trihydroxy-4,14,16-trimethyl-8-methylidene-17-tridecyl-1-oxa-4,9,12-triazacycloheptadeca-6,9,12-triene-2,5,15-trione

C30H49N3O7 (563.357)

(9s,10s,12s,14r,15z,26s)-9,19,21,26-tetramethyl-1-azacyclohexacosa-1,3,5,7,15,17,19,21,23-nonaene-2,10,12,14-tetrol

C29H41NO4 (467.3035)

(s)-{[(2s)-2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}[(1s,3s,4s,5r,8s)-2,4,5,8-tetrahydroxy-7-oxa-2-azabicyclo[3.2.1]octan-3-yl]acetic acid

C17H23N3O9 (413.1434)

9,18,20,26-tetramethyl-1-azacyclohexacosa-1,3,5,7,15,17,19,21,23-nonaene-2,10,11,12,14-pentol

C29H41NO5 (483.2985)

5-amino-4-(2-hydroxy-3,4-dimethoxyphenyl)-6-{6-methoxy-5,8-dioxo-7-[(3-oxobutan-2-yl)amino]quinolin-2-yl}-3-methylpyridine-2-carboxylic acid

C29H28N4O9 (576.1856)

(6e,14r,16s,17s)-10,13,14-trihydroxy-4,14,16-trimethyl-8-methylidene-17-pentadecyl-1-oxa-4,9,12-triazacycloheptadeca-6,9,12-triene-2,5,15-trione

C32H53N3O7 (591.3883)

4,7a,11a-trihydroxy-9-methyl-9,10-dihydro-8h-5-oxatetraphene-11,12-dione

C18H16O6 (328.0947)

6-{[(4z,6z,10z,14z,16z)-17-[({5-[2-(3,5-dichloro-2-ethyl-4,6-dihydroxyphenyl)-1-hydroxy-2-oxoethyl]-4-hydroxy-3-methoxy-6-methyloxan-2-yl}oxy)methyl]-9-ethyl-12-hydroxy-2-(1-hydroxyethyl)-5,7,11-trimethyl-18-oxo-1-oxacyclooctadeca-4,6,10,14,16-pentaen-8-yl]oxy}-4,5-dihydroxy-2,2-dimethyloxan-3-yl 2-methylpropanoate

C53H76Cl2O18 (1070.4408)

(6e)-8-{6-[(1e,3e,9e,11e,13e)-14-(4,5-dihydroxy-5,6-dimethyloxan-3-yl)-6-methoxy-11-methyl-8-oxotetradeca-1,3,9,11,13-pentaen-1-yl]-3-ethyl-4-hydroxy-5-methyloxan-2-yl}-5-hydroxy-3-methoxy-2,6-dimethyl-n-{2-methyl-1-[(4-methyl-2-oxo-5-phenyloxolan-3-yl)-c-hydroxycarbonimidoyl]propyl}oct-6-enimidic acid

C58H86N2O13 (1018.613)

2-[(3s,14s,15s)-5,13-dihydroxy-7,14-dimethyl-11-methylidene-2,8-dioxo-15-(pentadecan-2-yl)-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

C31H52N4O7 (592.3836)

16-ethyl-4-hydroxy-5,7,9,15-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,6,10-trione

C21H32O5 (364.225)

(3z)-pentadec-3-enenitrile

C15H27N (221.2143)

(1r,2s,3s,7r,8r,9r,10s,12r,14e,16s)-9-{[(2s,3s,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-10-[(2z)-4-oxopent-2-en-1-yl]-4,17-dioxabicyclo[14.1.0]heptadec-14-ene-5,13-dione

C34H55NO9 (621.3877)

(5z)-13-{[3,4-dihydroxy-4,6-dimethyl-5-(methylamino)oxan-2-yl]oxy}-5-propylidene-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),8,10,12-tetraen-2-one

C23H31N3O5 (429.2264)

(1r,9s,12s,15s,16e,20e,23r,24s,27r)-1-hydroxy-15,23,27-trimethyl-12-[(2r)-1-[(1s,2s,3s,4r)-2,3,4-trihydroxycyclohexyl]propan-2-yl]-11,28-dioxa-4-azatricyclo[22.3.1.0⁴,⁹]octacosa-16,20-diene-2,3,10,22-tetrone

C37H57NO10 (675.3982)

(1r,4s,6s,8s,10r,17s)-17-hydroxy-8,10-dimethyl-5-oxa-12-azatetracyclo[8.6.1.0⁴,⁶.0¹³,¹⁷]heptadec-13-ene-9,11,15-trione

C17H21NO5 (319.142)

methyl (1s,2s,4r)-2,4,5,7,12-pentahydroxy-6,11-dioxo-2-propyl-3,4-dihydro-1h-tetracene-1-carboxylate

C23H22O9 (442.1264)

(2s,3r,4s,5s)-2-{[(1r,2s,3r,4s,6r)-4-amino-3-{[(2s,3r,6r)-3-amino-6-[(1s)-1-aminoethyl]oxan-2-yl]oxy}-2,6-dihydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol

C20H40N4O8 (464.2846)

2-ethyl-1,8-dihydroxy-3-methylanthracene-9,10-dione

C17H14O4 (282.0892)

6-{[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexane-1,2,3,4,5-pentol

C12H23NO10 (341.1322)

n-[(2r,3r,4s,6r)-4-amino-6-{[(1r,5r,6s,7e,9s,11z,13s,16s,17s,18s,20r,21r,22s)-3-formyl-5,27-dihydroxy-17-{[(2r,4r,5r,6s)-4-{[(2s,5r,6s)-5-{[(2r,4r,5r,6r)-4-hydroxy-5-{[(2r,5r,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyl-5-[(2-methylpropanoyl)oxy]oxan-2-yl]oxy}-8,12,18,20,22-pentamethyl-23,25-dioxo-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-3,7,11,14,24(27)-pentaen-9-yl]oxy}-2,4-dimethyloxan-3-yl]methoxycarboximidic acid

C69H102N2O22 (1310.6924)

2-[(2-amino-1-hydroxypropylidene)amino]-3-({hydroxy[3-(c-hydroxycarbonimidoyl)oxiran-2-yl]methylidene}amino)propanoic acid

C10H16N4O6 (288.107)

(1s,16r,17r,19s)-16-{[(2s,4r,5s,6s)-5-acetyl-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-3,10-dihydroxy-17-methyl-4',5'-dihydro-1'h-18-oxaspiro[pentacyclo[15.2.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹]icosane-19,2'-pyrrolo[2,3-b]pyrrole]-2,4(13),6,8,10,14-hexaene-5,12-dione

C33H32N2O10 (616.2057)

1,6,10-trihydroxy-2-(4-hydroxy-5-{[4-hydroxy-6-methyl-5-({6-methyl-5-[(6-methyl-5-oxo-2,6-dihydropyran-2-yl)oxy]oxan-2-yl}oxy)oxan-2-yl]oxy}-6-methyloxan-2-yl)-8-methyltetracene-5,12-dione

C43H48O15 (804.2993)

9,17,23-trihydroxy-3,8,12,18,20,22-hexamethyl-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-4,7,11,14,23-pentaene-25,27-dione

C32H42O6 (522.2981)

2-[(1s,2r,3r,7r,8s,9r,10s,12s,14e,16s)-9-{[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde

C31H51NO9 (581.3564)

(3s,4s,5s)-5-{[(1s,2r,8ar)-1,2,5,5-tetramethyl-2,3,6,7,8,8a-hexahydronaphthalen-1-yl]methyl}-4-(chloromethyl)-4-hydroxy-2-oxooxolan-3-yl acetate

C22H33ClO5 (412.2016)

4-{2-[9,14-dihydroxy-8-methoxy-1,5,10,15,16-pentaoxo-3-(sec-butyl)-2-azahexaphen-2-yl]acetyl}-6-hydroxy-5-methyl-3,5-dihydro-2h-pyrazine-2-carboxylic acid

C38H31N3O12 (721.1908)

(2r,3r,6e,8s,9s,10s,12r,14e)-9-{[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-2-({[(2r,3r,4r,5r,6r)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxy}methyl)-8,10,12-trimethyl-4,17-dioxabicyclo[14.1.0]heptadeca-6,14-diene-5,13-dione

C37H61NO12 (711.4194)

(1s,2s,3r,4r,6r,8r,11r,13s,15r)-6-methyl-2-(2-oxopropyl)-16-oxapentacyclo[13.2.2.0¹,¹³.0³,¹¹.0⁴,⁸]nonadec-9-ene-7,17,18-trione

C22H26O5 (370.178)

(7ar,9r,11as)-4,7a,11a-trihydroxy-9-{[(2s,5s,6s)-5-{[(2s,4r,5r,6r)-5-hydroxy-4-{[(2s,5s,6s)-5-{[(2s,4r,5r,6r)-5-hydroxy-4-{[(2s,5s,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-3-[(2r,4r,5s,6r)-4-hydroxy-5-{[(2s,4s,6s)-4-hydroxy-6-methyl-5-{[(2s,5s,6s)-6-methyl-5-{[(2r,6s)-6-methyl-5-oxo-2,6-dihydropyran-2-yl]oxy}oxan-2-yl]oxy}oxan-2-yl]oxy}-6-methyloxan-2-yl]-9-methyl-8,10-dihydro-5-oxatetraphene-11,12-dione

C72H102O29 (1430.6506)